来自大肠杆菌的原型载体DtpA与瓦尔甘西克洛维尔复合的结构为人类PepT1的药物结合提供了洞察力
在PubMed上查看摘要
概括
此摘要是机器生成的。大肠杆菌DtpA的晶体结构揭示了抗病毒药物瓦尔甘西克洛维尔如何结合,模仿一种. 这一发现为设计通过溶液载体15载体更好吸收的药物提供了洞察力.
科学领域
- 生物化学
- 结构生物学
- 分子运输
背景情况
- 溶性载体15 (SLC15) 携带者家族介导二和三的吸收.
- 了解传送器与药物的相互作用对于优化药物输送至关重要.
- 大肠杆菌的DtpA载体与人类的PepT1 (SLC15A1) 有功能相似之处.
研究的目的
- 阐明DtpA输送器的连体结合的结构基础.
- 研究DtpA与抗病毒前药瓦尔甘西克洛维尔的相互作用.
- 提供与人类PepT1相关的结合机制的见解.
主要方法
- 用X射线结晶学来确定DtpA在无体和环结合状态中的结构.
- 支持结构发现的生物化学测试.
- 同质模型推断人类PepT1的结合模式.
主要成果
- 在3.30 Å (无) 和2.65 Å (与瓦尔甘环结合) 确定DtpA的晶体结构.
- 瓦尔甘西克洛维尔通过其甘西克洛维尔部分与DtpA结合,模仿基的N端残留物.
- 生物化学数据证实了观察到的结合模式.
结论
- DtpA-valganciclovir的结构显示出抗病毒前药物的意想不到的结合方式.
- 这种结合模式很可能保留在人类的PepT1转运器中.
- 这些发现将有助于合理设计具有增强吸收性的类药物.
相关概念视频
In eukaryotes, transcription and translation are compartmentalized; an mRNA is first synthesized in the nucleus and then selectively transported to the cytoplasm for protein synthesis. Before transport, a pre-mRNA undergoes several steps of post-transcriptional modifications including splicing, 5' capping, and the addition of a poly-adenine tail. Various proteins bind to the pre-mRNA during these modifications. The mRNA transport takes place with the help of multiple proteins playing...
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
Drug binding to proteins is a complex phenomenon influenced by various drug-related factors, each playing a significant role in the interaction between drugs and proteins within the body.
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
Body tissues, comprising approximately 40% of the body weight, are crucial in drug distribution and localization. These tissues can serve as drug storage sites, competing with plasma binding sites for drug molecules.
Drugs can bind to different tissue components, enhancing their distribution and localization. The factors influencing drug localization in tissues include the drug's lipophilicity, structural characteristics, tissue perfusion rate, and pH differences. These factors determine...
Drug interactions are a critical aspect of pharmacology and can occur when two or more drugs compete for the same binding site. This competition can result in one drug displacing another, altering the effect of the displaced drug. Drug interactions are complex processes that rely heavily on how much of the displacer drug is present and how strongly it can bind to the same sites as the displaced drug.
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
Upon entering the systemic circulation, drugs can distribute into the interstitial and intracellular fluid of various tissue cells. This distribution is facilitated by the binding of drugs to different cellular components within tissues, which may lead to drug accumulation in specific areas. Drugs bound to tissue components serve as reservoirs that release free drugs back into the system, prolonging the drug's overall action. However, this accumulation can also result in local toxicity.
For...

